Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma, Ewing × trilaciclib × 1 year × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 4 Triple Negative Breast Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Pathologic Complete Response 1 Neutropenia 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Limited Stage Small Cell Lung Cancer 1 Hemangiosarcoma 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1

Interventions

Temozolomide 12 Vincristine 8 Irinotecan 8 Cyclophosphamide 7 Etoposide 5 cabozantinib 4 X-Rays 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Ifosfamide 4 Doxorubicin 4 regorafenib 3 fludarabine 3 Topotecan 3 Radiotherapy 3 Radiation 3 Phantoms, Imaging 3 Melphalan 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 olaparib 2 liposomal doxorubicin 2 ivosidenib 2 irinotecan sucrosofate 2 etoposide phosphate 2 abemaciclib 2 Zoledronic Acid 2 Surgical Procedures, Operative 2 Sirolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡